US 11,925,466 B2
Implantable devices using 2D metal carbides and nitrides (MXenes)
Flavia Vitale, Wilmington, DE (US); Brian Litt, Bala Cynwyd, PA (US); Nicolette Driscoll, Philadelphia, PA (US); Yury Gogotsi, Ivyland, PA (US); Babak Anasori, Fisher, IN (US); and Kathleen Maleski, Mount Airy, MD (US)
Assigned to The Trustees of the University of Pennsylvania, Philadelphia, PA (US); and Drexel University, Philadelphia, PA (US)
Appl. No. 16/646,662
Filed by THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, Philadelphia, PA (US); and Drexel University, Philadelphia, PA (US)
PCT Filed Sep. 14, 2018, PCT No. PCT/US2018/051084
§ 371(c)(1), (2) Date Mar. 12, 2020,
PCT Pub. No. WO2019/055784, PCT Pub. Date Mar. 21, 2019.
Claims priority of provisional application 62/559,315, filed on Sep. 15, 2017.
Prior Publication US 2020/0405165 A1, Dec. 31, 2020
Int. Cl. A61N 1/05 (2006.01); A61B 5/24 (2021.01); A61B 5/283 (2021.01); A61B 5/296 (2021.01)
CPC A61B 5/283 (2021.01) [A61B 5/24 (2021.01); A61B 5/296 (2021.01); A61N 1/05 (2013.01)] 20 Claims
OG exemplary drawing
 
1. An electrode, comprising:
an exposed contact surface, the exposed contact surface comprising a contact material, the contact material comprising a MXene, and
the electrode being configured to monitor a signal related to neural activity, muscular activity, cardiac activity, or combinations thereof.